<DOC>
	<DOC>NCT02274857</DOC>
	<brief_summary>The study is a prospective, multicenter, randomized, single-blinded study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation.</brief_summary>
	<brief_title>Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Key At least two (2) documented episodes of persistent atrial fibrillation during prior 3 months Refractory, intolerant, or contraindicated to Class I or III antiarrhythmic medications Left atrial diameter &lt; 6.0 cm Key Presence of structural heart disease NYHA Class IV. Ejection fraction &lt; 35%. History of myocardial infarction (MI) within the past three months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>FIRMap</keyword>
	<keyword>Rotor</keyword>
	<keyword>FIRM-guided procedure</keyword>
	<keyword>REAFFIRM</keyword>
</DOC>